[go: up one dir, main page]

WO1994008551A3 - Pharmaceutical compositions and methods for treating cold symptoms - Google Patents

Pharmaceutical compositions and methods for treating cold symptoms Download PDF

Info

Publication number
WO1994008551A3
WO1994008551A3 PCT/US1993/008887 US9308887W WO9408551A3 WO 1994008551 A3 WO1994008551 A3 WO 1994008551A3 US 9308887 W US9308887 W US 9308887W WO 9408551 A3 WO9408551 A3 WO 9408551A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
methods
cold
cold symptoms
treating cold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1993/008887
Other languages
French (fr)
Other versions
WO1994008551A2 (en
Inventor
James Grigg Upson
Carmelita Macklin Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to CA002146637A priority Critical patent/CA2146637C/en
Priority to JP6510004A priority patent/JPH08502288A/en
Priority to EP93921692A priority patent/EP0662840A1/en
Priority to AU49307/93A priority patent/AU678561B2/en
Publication of WO1994008551A2 publication Critical patent/WO1994008551A2/en
Publication of WO1994008551A3 publication Critical patent/WO1994008551A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions comprising a safe and effective amount of at least one pharmaceutical cold active; 3-1-menthoxy propane 1,2-diol; and a pharmaceutically-acceptable carrier material suitable for oral or nasal administration. The present invention also includes methods for treating cough, cold, cold-like, allergy and/or flu symptoms in a human or lower animal, said method comprising administering to a human or lower animal in need of such treatment, by oral or nasal administration, a composition comprising 3-1-menthoxy propane 1,2-diol.
PCT/US1993/008887 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms Ceased WO1994008551A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002146637A CA2146637C (en) 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms
JP6510004A JPH08502288A (en) 1992-10-09 1993-09-22 Pharmaceutical composition and method for treating sensational symptoms
EP93921692A EP0662840A1 (en) 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms
AU49307/93A AU678561B2 (en) 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95501392A 1992-10-09 1992-10-09
US07/955,013 1992-10-09

Publications (2)

Publication Number Publication Date
WO1994008551A2 WO1994008551A2 (en) 1994-04-28
WO1994008551A3 true WO1994008551A3 (en) 1994-06-23

Family

ID=25496254

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/008887 Ceased WO1994008551A2 (en) 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms

Country Status (7)

Country Link
EP (1) EP0662840A1 (en)
JP (1) JPH08502288A (en)
AU (1) AU678561B2 (en)
CA (1) CA2146637C (en)
MX (1) MX9306295A (en)
NZ (1) NZ256346A (en)
WO (1) WO1994008551A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078066B2 (en) 1997-09-18 2006-07-18 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents and method of making

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168265T1 (en) * 1993-04-30 1998-08-15 Procter & Gamble COMPOSITIONS FOR RELEASING AN AROMATIC SUBSTANCE INTO THE NOSE
AU1716995A (en) * 1994-03-18 1995-10-09 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
CA2277911C (en) * 1997-01-13 2010-09-14 Emory University Compounds and their combinations for the treatment of influenza infection
GB9707977D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Centre filled confectionery
GB9707978D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Throat soothing compositions
DE19814256A1 (en) * 1998-03-31 1999-10-07 Asta Medica Ag Solid, fast-breaking cetirizine formulations
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
NZ532019A (en) * 2001-09-04 2007-04-27 Boehringer Ingelheim Int Anti-influenza drugs
MXPA04009617A (en) 2002-04-04 2005-01-11 Pfizer Prod Inc Palatable chewable tablet.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2006034495A2 (en) * 2004-09-23 2006-03-30 Matias Jonathan R Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
AU2016219620B2 (en) * 2006-04-21 2017-05-11 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
WO2012104571A1 (en) * 2011-02-02 2012-08-09 GILHOLM, Stephen, Philip Compositions of monoterpenoids for the treatment of influenza
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
EP3793535A1 (en) 2018-05-16 2021-03-24 Bayer Healthcare LLC High concentration suspension formulation for cold and flu soft gel capsule medications
CN112972439A (en) * 2019-12-16 2021-06-18 南京亿华药业有限公司 Yumei effervescent tablet and preparation method thereof
AU2021217209A1 (en) 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2127011A1 (en) * 1971-02-04 1972-10-13 Wilkinson Sword Ltd
WO1992017164A1 (en) * 1991-04-04 1992-10-15 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888334A (en) * 1981-11-20 1983-05-26 Takasago Corp 3-l-menthoxypropane-1,2-diol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2127011A1 (en) * 1971-02-04 1972-10-13 Wilkinson Sword Ltd
WO1992017164A1 (en) * 1991-04-04 1992-10-15 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078066B2 (en) 1997-09-18 2006-07-18 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents and method of making

Also Published As

Publication number Publication date
CA2146637C (en) 2001-02-13
WO1994008551A2 (en) 1994-04-28
EP0662840A1 (en) 1995-07-19
NZ256346A (en) 1997-04-24
MX9306295A (en) 1994-04-29
AU4930793A (en) 1994-05-09
JPH08502288A (en) 1996-03-12
AU678561B2 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
BG102689A (en) PHARMACEUTICAL AEROSOL COMPOSITION FOR USE IN TREATMENT OF RESPIRATORY DISORDERS
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
DK0799024T3 (en) Pharmaceutical aerosol containing at least one sugar
CA2125665A1 (en) Medicaments
ATE292982T1 (en) ANALGESIC SYNERGY THROUGH SIMULTANEOUS ADMINISTRATION OF SUBANALGESIC DOSES OF A MU-OPIOID ANAGONIST AND A KAPPA-2-OPIOID ANAGONIST
KR950002785A (en) Parathyroid hormone and raloxyphene to increase bone mass
DE69533112T2 (en) USE OF FLAVOLIGNANES FOR THE PRODUCTION OF MEDICINES WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, BREAST, EGGS
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
SG166294G (en) Inhalation medicaments for treating respiratory disorders
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
BG101118A (en) Therapeutical compounds
DE4497905T1 (en) Pharmaceutical composition for the prevention and treatment of motion sickness syndrome
WO2003024387A3 (en) Method and pharmaceutical composition for treating inflammation
NO952906D0 (en) Pharmaceutical formulation for the treatment of nicotine addiction
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
GR3015934T3 (en) Reduction or prevention of skin irritation by drugs.
UA35611C2 (en) Topical composition for inhibiting hair growth in mammals, method for application and topical composition for delivering water-soluble pharmaceutical to skin
MY117918A (en) Use of an h+, k+- atpase inhibitor in the treatment of nasal polyps
CA2120062A1 (en) Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
UA32457C2 (en) Drug (variants) and methods for exposure to drug
RU94040886A (en) Use of melatonine derivatives for sleep disturbance treatment, pharmaceutical composition
EP0744176A3 (en) Methods for inhibiting bone loss
MXPA04001912A (en) Novel aminobenzoephenones.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI JP KR NO NZ RU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI JP KR NO NZ RU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 256346

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2146637

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993921692

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993921692

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993921692

Country of ref document: EP